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INTRODUCTION
The hemophilias are X-linked congenital bleeding disorders,
and the two major categories are hemophilia A (factor VIII defi-
ciency, seen in 1 in 5,000 male births) and hemophilia B (factor
IX deficiency, seen 1 in 30,000 male births) [1]. Despite the fact
that medical management of hemophilia is undertaken by a team
of experts at specialized centers and the use of prophylactic
clotting factor infusions at home, many patients with hemophilia
still continue to seek medical attention for injuries or bleeding
complications in the emergency department (ED). An emerging
cause of ED visits among patients with hemophilia is infections
related to central venous catheters (CVCs). These are used for
prophylactic clotting factor infusions given at home, or immune
tolerance induction therapy in patients with hemophilia who
have developed neutralizing antibodies against clotting factors
(inhibitors).
In this retrospective study, we examined the overall ED use by
patients with hemophilia in a single center, particularly in order to
examine visits related to an injury or bleeding, or a bloodstream
infection in patients with CVC.
MATERIALS AND METHODS
This study was approved by the Human Investigation Commit-
tee of Wayne State University. Electronic medical records of all
ED visits to Children’s Hospital of Michigan were reviewed for
all patients with hemophilia, aged 0–21 years, presenting over a
5-year period, between January 1st, 2006 and December 31st,
2010. Patients presenting to the ED were identified mainly
through the medical records department, which provided a list
of all encounters in the ED with the ICD-9 codes 286.0 and 286.1
for congenital factor VIII and factor IX deficiencies, respectively.
In addition, the patients listed at our hemophilia care center were
screened for ED visits during the study period.
Data collected included age at presentation, type of hemophilia,
degree of severity of hemophilia, inhibitor status, and reason for
presentation. Severity of hemophilia was classified as severe,
moderate, or mild for factor levels <1%, 1%–5%, or 5%–25%,
respectively. A patient with inhibitor was defined as a patient with
a positive inhibitor titer 0.6 Bethesda Unit/ml with Nijmegen
modification when applicable, either at the time of the ED visit or
in the past.
ED visits were categorized as visits related to: (1) injury or
bleeding; (2) evaluation for a suspected CVC-related infection,
including fever or positive blood culture in a patient with CVC;
(3) general pediatric causes unrelated to hemophilia; and (4)
routine clotting factor infusion. The injury or bleeding category
encompassed history of trauma to a body part; fall, fight, or motor
vehicle accident without referencing a specific body part; swelling
or pain in a body part with a suspicion for bleeding, even when
there is no history of an identifiable episode of trauma; and visible
bruising or bleeding. For patients who had head CT imaging,
these results were also examined for the presence of ICH, subcu-
taneous hematoma of the scalp, and other findings. Positive blood
cultures were considered a contamination if the cultures grew a
known skin contaminant [2] (e.g., Staphylococcus epidermidis)
and both the repeat cultures before antibiotic treatment and the
peripheral cultures remained negative.
RESULTS
Demographics
The medical records department identified 83 patients with
ICD-9 codes for hemophilia who presented to the ED during
the study period. Six of these were excluded because of erroneous
coding (congenital deficiencies of factors V, VII, and XIII in three
patients; combined factor V and VIII deficiency in one patient;
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plasminogen activator inhibitor-1 deficiency in one patient; and
malingering in one patient). Our hemophilia treatment center list
included 100 patients as of end of 2011, and we identified addi-
tional 31 patients with hemophilia that were not in the list pro-
vided by the medical records department; however, only six of
these had visited the ED during the study period. Therefore, in
total, there were 536 ED visits from 84 male patients (75 with
hemophilia A and 9 with hemophilia B) over the 5-year period.
The median presentation age for ED visits was 4 years (range
0–21), while the mean age was 6.7 years. Racial or ethnic origin
was Caucasian for 33 patients, African American for 40 patients,
Hispanic for 2 and other (Middle Eastern, Asian) for 9. Eighty of
the patients were followed at our institution; the other four were
followed at outside centers. Five patients also had other chronic
conditions: sickle cell anemia in two patients and Down syn-
drome, Crohn disease, and myelomeningocele in one patient
each. Serologic information was available for the 79 patients
followed at our center, and these patients were seronegative for
Human Immunodeficiency Virus-1 (HIV-1). HIV infection was
negative by history for the four patients followed at outside insti-
tutions and one patient who was more recently diagnosed. Distri-
bution of ED visits per year was as follows: 85 (2006); 111
(2007); 108 (2008); 124 (2009); and 108 (2010).
Hemophilia Type and Severity
Among patients with hemophilia A, there were 52 patients
with severe disease, 9 with moderate and 10 with mild. The
disease severity was unknown in 4 patients. Among patients
with hemophilia B, 3 were severely affected, 4 moderate, and
2 mild.
ED Visits in General
Whereas 26.2% (n ¼ 22) of the patients visited the ED only
once during the study period, the patient with the highest number
of visits had 43 ED visits (median three visits per patient).
Patients with hemophilia A constituted 86.6% (n ¼ 464) of all
ED visits whereas patients with hemophilia B constituted 13.4%
(n ¼ 72) of the visits. In visits where severity was known (98.5%
of total, n ¼ 528); severe, moderate, and mild hemophilia com-
prised 70.3%, 21.2%, and 8.5% of the ED visits, respectively.
The reasons for ED visits were as follows: 61.2% (n ¼ 328)
were for injury or bleeding; 11.8% (n ¼ 63) for evaluation of a
suspected CVC-related infection; 19.2% (n ¼ 103) for pediatric
causes unrelated to hemophilia; and 7.8% (n ¼ 42) for routine
clotting factor infusion for inability to infuse at home. Routine
factor infusions category included 17 patients whose parents were
yet in the process of learning intravenous access and infusion, and
included visits either for prophylactic infusions or on demand
infusions for previously diagnosed bleeding episodes (i.e., the
ED visit was not for the bleeding problem).
ED Visits for Injury or Bleeding
Visits for injury or bleeding comprised the most common
reason for an ED visit in hemophiliac patients. These episodes
were to the following body sites: extremities (n ¼ 143); back
(n ¼ 4); abdomen (n ¼ 10); chest (n ¼ 5); gastrointestinal
(n ¼ 3); genitourinary (n ¼ 10); oral (n ¼ 30); ocular (n ¼ 5);
and facial-cranial region (n ¼ 90). In addition, cases of headache
(without a history of cranial injury) with concern for intracranial
bleeding (n ¼ 6); CVC-related bleeding/swelling (n ¼ 5); post-
circumcision bleeding (n ¼ 6); epistaxis (n ¼ 4); injury to multi-
ple sites (n ¼ 6); and one infant who presented with lethargy and
vomiting, who was subsequently discovered to have bilateral
iliopsoas muscle hematoma and intracranial bleeding; were also
included within this category.
Eighteen of the visits from six patients were because of a
bleeding episode in patients not yet diagnosed with hemophilia.
These visits were for circumcision site bleeding (n ¼ 3), post-
surgical abdominal hematoma (n ¼ 1), extremity injury (n ¼ 11),
head injury (n ¼ 2), and oral bleeding (n ¼ 1). Three of these
patients visited the ED for bleeding symptoms only once prior to
being diagnosed with hemophilia; the other three visited the ED 2,
4, and 16 times for bleeding symptoms prior to being diagnosed
with hemophilia.
Evaluation for ICH
Computerized tomographic (CT) examination of the head was
undertaken in 86 of the visits from 43 patients. (One patient with
moderate hemophilia B had 11 cranial CT examination requests
from ED visits during the study period.) Reasons for obtaining the
CT examination included either suspected or definite trauma to
the facial-cranial region (n ¼ 77) or other symptoms such as
headache (n ¼ 6), lethargy (n ¼ 1), pallor (n ¼ 1), and vomiting
(n ¼ 1). In six patients with head injury, the cranial CT examina-
tion was deferred because of a normal neurologic examination;
none of the six were subsequently found to have ICH.
Cranial CT examinations yielded negative results in 43%
(n ¼ 37); scalp soft tissue swelling/hematoma in 39.5%
(n ¼ 34); and other results in 11.6% (n ¼ 10) of the studies.
Other results included nasal fracture; scalp defect; encephaloma-
lacia; and arachnoid cyst. Overall, only 5.8% (n ¼ 5) of the
cranial CT examinations showed ICH. These patients had pre-
sented with head trauma (n ¼ 3), vomiting (n ¼ 1), and headache
(n ¼ 1). Table I summarizes the clinical presentation of cases
with ICH.
Evaluation for a Suspected CVC-Related
Bloodstream Infection
Sixty-three visits were for the evaluation for a suspected CVC-
related bloodstream infection: either because of fever in a patient
with CVC (n ¼ 53) or because of positive results of a blood
culture drawn earlier from a CVC (n ¼ 10). Thirty-three of the
blood cultures were positive; however, only 29 of these repre-
sented distinct episodes of bloodstream infections (5.4% of all
visits). Two of the cultures were repeat draws after a positive
culture drawn in the ED the day before, and two were skin
contaminants, that included coagulase-negative Staphylococci
from a surveillance blood culture on an asymptomatic patient
and nutritionally deficient Streptococci from a febrile patient
with symptoms suggestive of a viral upper respiratory infection.
A peripheral culture that grew Staphylococcus hominis was also
excluded based on these criteria, although the simultaneous cen-
tral blood culture that grew Serratia plymuthica was included.
The 29 distinct episodes of bloodstream infections represented
46% of all visits for a suspected CVC-related bloodstream infec-
tion, and were from 22 febrile visits and seven recalls for a new
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positive blood culture. These episodes were from nine patients, all
with severe hemophilia A (six with inhibitors). These cultures
grew single gram-positive bacteria in 12 cases, single gram-nega-
tive bacteria in 10, and multiple organisms, including two with
Candida species, in seven cases.
DISCUSSION
The ED of hospitals constitutes an indispensable component of
the pediatric hemophilia care, as it serves as a de facto after-hours
clinic for bleeding complications, injuries, and routine clotting
factor infusions. A patient with undiagnosed hemophilia may
first seek medical attention for bleeding in the ED, and therefore
the ED visit may also be important in making a timely diagnosis
for hemophilia patients. Two previous studies, one from the
1980’s and the other from 1998, analyzed ED visits of hemophilia
patients [3,4]. In the earlier study, 126 ED visits were noted (for
bleeding or injury only) in a single center over a 10-year-period
[3]. In the latter study, which included both pediatric and adult ED
visits to 25 hospitals, 125 visits were noted over a 1-year-period
(64.8% for bleeding episodes) [4]. Since then, many more patients
are being treated with prophylactic infusions at home, which is
now considered the standard of care [5]. Some patients in these
early surveys were afflicted with the HIV-1 infection, which is
no longer a problem for the new generations of patients with
hemophilia, and none of the patients in the current study were
HIV-positive [6].
The annual rate of pediatric ED visits was 107.2 per year
among patients with hemophilia in the current study, that is, an
ED visit every 3–4 days. Compare this high rate to a previous
survey of ED use among children enrolled in Michigan’s Child-
ren’s Special Health Care Services (CSHCS), which revealed 148
visits from hemophilia patients between January 1998 and
June 1999 in the entire state of Michigan [7]. This difference
could be explained by the fact that our ED is part of a hemophilia
center, and our patient population may not be representative of
patients with hemophilia presenting to a general ED.
Bleeding or injury were the most common cause of ED visits
among hemophilia patients in our study, comprising 61.2% of all
visits. This category was also the most common reason for ED
visits among two earlier surveys of hemophilia patients [3,4].
Injury without signs of bleeding was also included in this catego-
ry, as muscle, joint, or tissue bleeding is an anticipated outcome
of injury in patients with hemophilia, and injuries require treat-
ment with clotting factor infusions even in the absence of clinical
symptoms.
During the study period, six previously undiagnosed patients
visited the ED 18 times for injury or bleeding episodes. Although
rare (3.6 visits per year), the emergency physician should be
vigilant for patients presenting with unusual bleeding episodes,
and a detailed personal and family history of bleeding should be
obtained in such cases. However, there may be no family history
of hemophilia, either because of a lack of affected members, or
because of a de novo mutation (approximately one-third of cases)
[8]. Most undiagnosed hemophilia patients initially present to the
ED, and it is not uncommon for the patient to see a doctor several
times before finally being diagnosed with the hemophilia [9].
Appropriate screening tests include: complete blood count; pro-
thrombin time; activated partial thromboplastin time (aPTT); and
fibrinogen. Isolated prolongation of aPTT suggests hemophilia,
and factor VIII and IX activity should be obtained in such cases in
addition to testing for a circulating anticoagulant and von Wille-
brand disease. It is also important to realize that some patients
with mild hemophilia may present with no or only minimal pro-
longation of the aPTT [10].
All patients suspected to have a bleeding disorder should be
evaluated by a pediatric hematologist. The bleeding episode itself
could provide clues to the ED physician: persistent bleeding, drop
in hematocrit during the bleeding episode, bleeding where the
severity is disproportionate to the trauma, or bleeding at unusual
TABLE I. Clinical Characteristics of the Patients With Intracranial Hemorrhage
Age Disease Presentation
Abnormal
neurologic findings CT findings
7 months Severe hemophilia A no inhibitors
not on prophylaxis
Vomiting, concomitant
bilateral iliopsoas
muscle hematoma on
ultrasonographic study
(trauma not reported)
None Large left temporal lobe hematoma
4 years Severe hemophilia A no inhibitors
not on prophylaxis, sickle cell
anemia
Head injury, fever,
vomiting, jerking of right
arm, headache
Decreased strength
in the right arm
Extra-axial hemorrhage along left
parietal convexity
6 years Severe hemophilia A no inhibitors
receiving prophylaxis
Head injury, lethargy Occipital contusion;
altered mental
status
Small right frontal parenchymal
hematoma; posterior occipital
subcutaneous hematoma; linear
fracture of occipital bone
15 years Severe hemophilia A past history of
inhibitors receiving prophylaxis
prior history of intracranial
hemorrhage
Headache, photophobia None Subdural hemorrhage along left
cerebral convexity;
encephalomalacia
17 years Severe hemophilia B no inhibitors
receiving prophylaxis
Head injury, headache None Small extra-axial hemorrhage
anterior to the left frontal lobe
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sites are all suspicious for a bleeding disorder. Early suspicion
of a bleeding disorder, and timely referral for hematologic evalu-
ation are important in preventing ongoing musculoskeletal dam-
age, or even a fatal outcome, from bleeding episodes in patients
with hemophilia.
ICH, the most dreaded complication of hemophilia, was fortu-
nately rare in our study: five patients, representing 0.9% of all
hemophilia visits to the ED, over a 5-year period. ICH occurs in
3–10% of the hemophilia population after the neonatal period
[11], and is more common among patients with severe hemophil-
ia, those with inhibitors, or those with a history of prior ICH [12].
Prophylactic factor treatment is one of the measures that can be
used to reduce the risk of post-neonatal ICH (in patients without
an inhibitor) [12,13]. ICH can occur without a history of head
trauma [11–13]. In two of the visits we noted, there was no history
of head trauma, and all of these patients had severe hemophilia.
Cranial CT imaging is an important tool for evaluation for ICH
in patients presenting with head trauma; however, it should be
used judiciously as it exposes the child to cranial radiation, as for
the child who had 11 cranial CT examinations [14]. Obviously, it
is difficult to arrive at good guidelines for selecting patients with
hemophilia and head injury who could be observed alone without
obtaining a cranial CT. The emergency physician, in consultation
with the hematologist, should take into account multiple factors,
including the mechanism and severity of the injury; loss of con-
sciousness after the injury; presenting symptoms; physical exam-
ination findings; and disease-associated factors such as the
severity of hemophilia, presence of inhibitors, and prophylactic
treatment; in order to formulate a judicious management plan.
Factor infusion to correct to 100% activity level should be pro-
vided without delay [15].
CVC-related infections occur in 44% of patients with hemo-
philia with CVCs according to a meta-analysis (pooled incidence
of 0.66 per 1000 catheter-days), and requires prompt medical
attention and institution of antibiotic therapy once blood cultures
have been obtained [16,17]. Evaluation for a suspected CVC-
related bloodstream infection (fever or positive blood culture)
constituted 11.8% of all ED visits in patients with hemophilia
in the current study. We included fever in a patient with hemo-
philia without a CVC within general pediatric visits, because we
wanted to examine the impact of CVC use in patients with hemo-
philia separately.
Patients with inhibitors have been noted to have a higher risk
of infection [16][18], and interestingly six of the nine patients that
did have positive blood cultures either had inhibitors or had a
past history of inhibitors. Patients with inhibitors commonly are
candidates for daily immune tolerance induction treatment or may
need to receive bypassing agents (e.g., recombinant human factor
VIIa) several times a day for bleeding episodes, and therefore
may have to access the CVC more frequently than patients re-
ceiving factor infusions for prophylaxis or on demand treatments.
Additionally, patients with inhibitors may develop bleeding around
the port, which may predispose to a CVC infection [19]. In fact, the
presence of an inhibitor was noted to be the strongest predictor for a
CVC infection in a previous study [20]. Gram-positive bacteria,
especially Staphylococcus aureus or S. epidermidis, are the
most commonly cultured organisms in CVC-related bloodstream
infections of patients with hemophilia [21].
The emergency physician should note that a significant pro-
portion (42%) of febrile visits in children with hemophilia with a
CVC resulted in a significant bloodstream infection in the current
study. CVC-related infections can cause serious complications
(such as septic arthritis or bacterial endocarditis, etc.) [21], or
prove fatal in patients with hemophilia, as reported in a patient
with hemophilia A and an inhibitor who presented with S. aureus
bacteremia [22]. Fever in a patient with hemophilia with CVC is
therefore a serious symptom, and necessitates commencing em-
pirical antimicrobial treatment as soon as possible while awaiting
culture results.
In conclusion, the pediatric emergency physician is commonly
challenged not only with hemorrhagic complications of hemophil-
ia, but also with suspected CVC-related bloodstream infections in
febrile patients. Although less common, undiagnosed patients
with hemophilia may also present with their first hemorrhagic
episode to the ED. The emergency physician therefore should
be knowledgeable not only in the management of the complica-
tions of hemophilia, but also in the investigation of a suspected
bleeding disorder.
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